Natural inducers of NRF2 such as apigenin [17] and curcumin [18] have demonstrated beneficial effects in animal models of NAFLD, underscoring the therapeutic promise of NRF2 activation [19]. Here, NFE2L2 is linked to metabolic dysfunction-associated steatotic liver disease.